Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 7,956 shares at $32.75 ($261K) on 2023-11-22, disclosed to the SEC on 2023-11-24.
Open-market sale of $261k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.75 | 3,901 | $128K | 49.0% |
| 2 | $32.75 | 3,901 | $128K | 49.0% |
| 3 | $33.52 | 154 | $5K | 2.0% |
| Total | $32.76 avg | 7,956 | $261K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |